Homoharringtonine Inhibits Allergic Inflammations by Regulating NF- κB-miR-183-5p-BTG1 Axis

We present evidence that NF-κB-miR-183-5p-BTG1 axis can serve as target for development of anti-allergy drug.

Source: Frontiers in Pharmacology - July 6, 2020 Category: Drugs & Pharmacology Source Type: research